Recently, Chen et al. (2021) (46) suggested that deregulated p16-CDK4/6-RB signaling is a cooperating event in the progression of MEC with the CRTC1-MAML2 fusion. The gene discussed is CDK4; the disease is mucoepidermoid carcinoma.